Coloplast Total Operating Expenses from 2010 to 2026
| CBHD Stock | EUR 65.64 1.40 2.18% |
Total Operating Expenses | First Reported 2017-03-31 | Previous Quarter 5 B | Current Value 5.2 B | Quarterly Volatility 879.9 M |
Check Coloplast financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Coloplast's main balance sheet or income statement drivers, such as Interest Expense of 960 M, Selling General Administrative of 6.8 B or Total Revenue of 20.3 B, as well as many indicators such as . Coloplast financial statements analysis is a perfect complement when working with Coloplast Valuation or Volatility modules.
Coloplast | Total Operating Expenses |
The Total Operating Expenses trend for Coloplast AS offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Coloplast is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Coloplast's Total Operating Expenses Growth Pattern
Below is the plot of the Total Operating Expenses of Coloplast AS over the last few years. It is the total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses. Coloplast's Total Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Coloplast's overall financial position and show how it may be relating to other accounts over time.
| Total Operating Expenses | 10 Years Trend |
|
Total Operating Expenses |
| Timeline |
Coloplast Total Operating Expenses Regression Statistics
| Arithmetic Mean | 13,043,076,471 | |
| Geometric Mean | 12,343,289,081 | |
| Coefficient Of Variation | 35.24 | |
| Mean Deviation | 3,686,207,612 | |
| Median | 12,383,000,000 | |
| Standard Deviation | 4,596,811,748 | |
| Sample Variance | 21130678.2T | |
| Range | 14.4B | |
| R-Value | 0.89 | |
| Mean Square Error | 4619435.1T | |
| R-Squared | 0.80 | |
| Slope | 811,678,431 | |
| Total Sum of Squares | 338090852T |
Coloplast Total Operating Expenses History
About Coloplast Financial Statements
Coloplast stakeholders use historical fundamental indicators, such as Coloplast's Total Operating Expenses, to determine how well the company is positioned to perform in the future. Although Coloplast investors may analyze each financial statement separately, they are all interrelated. For example, changes in Coloplast's assets and liabilities are reflected in the revenues and expenses on Coloplast's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Coloplast AS. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Operating Expenses | 22.7 B | 14 B |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Coloplast Stock
Coloplast financial ratios help investors to determine whether Coloplast Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Coloplast with respect to the benefits of owning Coloplast security.